TOP2A and neoplasm: Here, we showed that fisetin inhibited the transcription of topoisomerase II A (TOP2A) enzyme in human HepG-2 and Suit-2 cancer cells and that could be responsible, in part, for the anti-tumor effect of fisetin on those cells.